These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12355505)

  • 1. Microchimerism in systemic sclerosis: comment on the article by Johnson et al.
    Roberts-Thomson PJ; Walker JG; Hakendorf P; Smith MD; Ahern MJ
    Arthritis Rheum; 2002 Sep; 46(9):2538; author reply 2538-9. PubMed ID: 12355505
    [No Abstract]   [Full Text] [Related]  

  • 2. [Microchimerisme in systemic sclerosis].
    Aractingi S; Regnier S
    Ann Med Interne (Paris); 2002 May; 153(3):189-91. PubMed ID: 12218902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comment on the article "Hypocomplementemia in systemic sclerosis" by Cuomo G. et al.
    Hudson M; Steele R; Lu Y
    Reumatismo; 2009; 61(2):156-8; author reply 158. PubMed ID: 19633804
    [No Abstract]   [Full Text] [Related]  

  • 4. Quantification of fetal microchimeric cells in clinically affected and unaffected skin of patients with systemic sclerosis.
    Sawaya HH; Jimenez SA; Artlett CM
    Rheumatology (Oxford); 2004 Aug; 43(8):965-8. PubMed ID: 15199216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cigarette smoking in patients with systemic sclerosis reduces overall survival: comment on the article by Hudson et al.
    Hissaria P; Roberts-Thomson PJ; Lester S; Ahern MJ; Smith MD; Walker JG
    Arthritis Rheum; 2011 Jun; 63(6):1758-9. PubMed ID: 21437869
    [No Abstract]   [Full Text] [Related]  

  • 6. Systemic sclerosis sine scleroderma: comment on the article by Poormoghim et al.
    Slobodin G; Rosner I; Rozenbaum M; Naschitz JE; Zuckerman E; Yeshurun D; Rappaport B
    Arthritis Rheum; 2000 Nov; 43(11):2618. PubMed ID: 11083297
    [No Abstract]   [Full Text] [Related]  

  • 7. HLA-DQA1 is not an apparent risk factor for microchimerism in patients with various autoimmune diseases and in healthy individuals.
    Artlett CM; O'Hanlon TP; Lopez AM; Song YW; Miller FW; Rider LG
    Arthritis Rheum; 2003 Sep; 48(9):2567-72. PubMed ID: 13130476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DQA1 as a risk factor for microchimerism: comment on the article by Artlett et al.
    Lambert NC
    Arthritis Rheum; 2004 Aug; 50(8):2713. PubMed ID: 15334494
    [No Abstract]   [Full Text] [Related]  

  • 9. Limitations of the findings regarding the relationship between N-terminal pro-brain natriuretic peptide and systemic sclerosis-related pulmonary arterial hypertension: comment on the article by Allanore et al.
    Dimitroulas T; Giannakoulas G; Karvounis H; Settas L
    Arthritis Rheum; 2008 Jul; 58(7):2215-6; author reply 2216. PubMed ID: 18576342
    [No Abstract]   [Full Text] [Related]  

  • 10. Are the Short Form 36 physical and mental component summary scores useful measures in patients with systemic sclerosis? Comment on the article by Rannou et al.
    Hudson M; Thombs B; Baron M
    Arthritis Rheum; 2007 Oct; 57(7):1339; author reply 1339-40. PubMed ID: 17907215
    [No Abstract]   [Full Text] [Related]  

  • 11. What kind of durometer is best suited for the assessment of skin disease in systemic sclerosis? Comment on the article by Kissin et al.
    Kuwahara Y; Shima Y; Kawai M; Hagihara K; Hirano T; Arimitsu J; Narazaki M; Ogata A; Tanaka T; Kawase I; Ogiwara A
    Arthritis Rheum; 2008 Apr; 59(4):601. PubMed ID: 18383411
    [No Abstract]   [Full Text] [Related]  

  • 12. Elective pregnancy termination and microchimerism: comment on the article by Khosrotehrani et al.
    McGrath H
    Arthritis Rheum; 2004 Sep; 50(9):3058-9; author reply 3059. PubMed ID: 15457487
    [No Abstract]   [Full Text] [Related]  

  • 13. Microchimerism in Japanese women patients with systemic sclerosis.
    Murata H; Nakauchi H; Sumida T
    Lancet; 1999 Jul; 354(9174):220. PubMed ID: 10421308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Feto-maternal microchimerism in connective tissue diseases.
    Gannagé M; Amoura Z; Lantz O; Piette JC; Caillat-Zucman S
    Eur J Immunol; 2002 Dec; 32(12):3405-13. PubMed ID: 12432571
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of stressful life events in patients with systemic sclerosis.
    Chen Y; Huang JZ; Qiang Y; Wang J; Han MM
    J Zhejiang Univ Sci B; 2008 Nov; 9(11):853-6. PubMed ID: 18988303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Familial scleroderma: do environmental factors, genes and microchimerism share the same relevance?
    Del Rosso A; Pignone A; Giacomelli R; Cerinic MM
    J Eur Acad Dermatol Venereol; 2001 Jan; 15(1):11-4. PubMed ID: 11451311
    [No Abstract]   [Full Text] [Related]  

  • 17. Endothelial apoptosis in scleroderma: comment on the article by Black et al.
    Stefanec T
    Arthritis Rheum; 1999 Nov; 42(11):2491. PubMed ID: 10555046
    [No Abstract]   [Full Text] [Related]  

  • 18. Microchimerism in human diseases.
    Aractingi S; Uzan S; Dausset J; Carosella ED
    Immunol Today; 2000 Mar; 21(3):116-8. PubMed ID: 10689298
    [No Abstract]   [Full Text] [Related]  

  • 19. Skewed X chromosome inactivation in scleroderma: comment on the article by Ozbalkan et al.
    McGrath H
    Arthritis Rheum; 2005 Nov; 52(11):3679; author reply 3679-80. PubMed ID: 16258909
    [No Abstract]   [Full Text] [Related]  

  • 20. Failure to detect antinucleosome antibodies in scleroderma: comment on the article by Amoura et al.
    Hmida Y; Schmit P; Gilson G; Humbel RL
    Arthritis Rheum; 2002 Jan; 46(1):280-2. PubMed ID: 11817606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.